Literature DB >> 9989272

Isolation and characterization of two distinct forms of liver fatty acid binding protein from the rat.

E J Murphy1, R D Edmondson, D H Russell, S Colles, F Schroeder.   

Abstract

Liver fatty acid binding protein (L-FABP) appears to contain several different forms that may result from post-translational modification or bound ligand. To further assess this possibility, L-FABP was purified from rat liver homogenate and two putative isoforms separated using a sulfonyl column, a strong cation exchange resin. Fraction I eluted at 0.2 M NaCl, had a pI of 7.59, and following a final size exclusion step contained > 98% L-FABP. Fraction II eluted at 1.0 M NaCl, had a pI of 7.59, and following a final size exclusion step contained > 99% L-FABP. Both fractions contained approx. 0.15 moles of endogenous bound fatty acid per mole of protein, while L-FABP not subjected to the cation exchange step contained 0.75 moles of fatty acid per mole of protein. Fractions I and II had a greater proportion of saturated and monounsaturated fatty acids with a large reduction in polyunsaturated fatty acids compared to L-FABP not fractionated by cation exchange. Mass spectral analysis indicated the molecular mass of Fraction I was 14,315.02 +/- 0.35 Da and Fraction II was 14,315.86 +/- 0.34 Da. The peptide map for each fraction was determined by limited digestion of each fraction with either trypsin, Asp-N, or chymotrypsin to yield overlapping peptide fragments. Mass spectral analysis of these digests indicated the two proteins had identical amino acid fragments and that Cys69 was reduced and there were no Asn to Asp exchanges. Hence, these two forms of L-FABP were not isoforms and were not the result of differences in bound fatty acid. It is proposed that these two distinct forms of rat L-FABP were structural conformers based on two alternative folding pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989272     DOI: 10.1016/s0005-2760(98)00150-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Liver and intestinal fatty acid-binding protein expression increases phospholipid content and alters phospholipid fatty acid composition in L-cell fibroblasts.

Authors:  E J Murphy; D R Prows; T Stiles; F Schroeder
Journal:  Lipids       Date:  2000-07       Impact factor: 1.880

Review 2.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

3.  Glucose regulates fatty acid binding protein interaction with lipids and peroxisome proliferator-activated receptor α.

Authors:  Heather A Hostetler; Madhumitha Balanarasimha; Huan Huang; Matthew S Kelzer; Alagammai Kaliappan; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2010-07-13       Impact factor: 5.922

4.  Fluorescent n-3 and n-6 very long chain polyunsaturated fatty acids: three-photon imaging in living cells expressing liver fatty acid-binding protein.

Authors:  Avery L McIntosh; Huan Huang; Barbara P Atshaves; Elizabeth Wellberg; Dmitry V Kuklev; William L Smith; Ann B Kier; Friedhelm Schroeder
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

5.  FABP-1 gene ablation impacts brain endocannabinoid system in male mice.

Authors:  Gregory G Martin; Sarah Chung; Danilo Landrock; Kerstin K Landrock; Huan Huang; Lawrence J Dangott; Xiaoxue Peng; Martin Kaczocha; Drew R Seeger; Eric J Murphy; Mikhail Y Golovko; Ann B Kier; Friedhelm Schroeder
Journal:  J Neurochem       Date:  2016-06-22       Impact factor: 5.372

Review 6.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

7.  L-FABP directly interacts with PPARalpha in cultured primary hepatocytes.

Authors:  Heather A Hostetler; Avery L McIntosh; Barbara P Atshaves; Stephen M Storey; H Ross Payne; Ann B Kier; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2009-03-16       Impact factor: 5.922

8.  Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes.

Authors:  Avery L McIntosh; Barbara P Atshaves; Heather A Hostetler; Huan Huang; Jason Davis; Olga I Lyuksyutova; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Arch Biochem Biophys       Date:  2009-03-12       Impact factor: 4.013

9.  Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels.

Authors:  Gregory G Martin; Sarah Chung; Danilo Landrock; Kerstin K Landrock; Lawrence J Dangott; Xiaoxue Peng; Martin Kaczocha; Eric J Murphy; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2016-07-23       Impact factor: 1.880

10.  Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat.

Authors:  Gregory G Martin; Drew R Seeger; Avery L McIntosh; Sarah Chung; Sherrelle Milligan; Danilo Landrock; Lawrence J Dangott; Mikhail Y Golovko; Eric J Murphy; Ann B Kier; Friedhelm Schroeder
Journal:  Arch Biochem Biophys       Date:  2018-05-12       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.